Intervention phase of the Tehran Lipid and Glucose Study (TLGS phase II)

Recruiting

• Conditions: on-communicable diseases (NCD); Not Applicable

• Registration Number: ISRCTN52588395
• Lead Sponsor: Research Institute for Endocrine Sciences (Iran)

Brief Summary

1. 2000 rationale and design in Azizi F, Rahmani M, Emami, H, Majid M. Tehran lipid and glucose study (TLGS): rationale and design. CVD Prevention 2000; 3:50-3. 2. 2002 results in http://www.ncbi.nlm.nih.gov/pubmed/12643001 3. 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17999777 4. 2008 nutritional intervention results in http://www.ncbi.nlm.nih.gov/pubmed/18349527 5. 2008 anthropometric parameter results in http://www.ncbi.nlm.nih.gov/pubmed/18772585 6. 2008 nested case control study results in http://www.ncbi.nlm.nih.gov/pubmed/18533046 7. 2008 assessment of alternative definitions results in http://www.ncbi.nlm.nih.gov/pubmed/18282630 8. 2008 prospective study results in http://www.ncbi.nlm.nih.gov/pubmed/18068961 9. 2009 phase II protocol in http://www.ncbi.nlm.nih.gov/pubmed/19166627 10. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20494239 11. 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/28795355

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-11-27
• Last Update Posted: 10 December 2018
• Study Completion: 2020-03-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 15005

Inclusion Criteria

1. Individuals aged 3 years and over, either sex
2. Residents of the District 13 of Tehran
3. Under the coverage of three medical health centres, selected using multistage cluster random sampling method
4. Agree for all members of each family, including those not having risk factors, to be enrolled

Exclusion Criteria

Mentally disabled persons

Study & Design

• Study Type: Interventional
• Study Design: Not specified